Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Non-cash Items: 2017-2024

Historic Non-cash Items for Protagonist Therapeutics (PTGX) over the last 8 years, with Dec 2024 value amounting to $4.9 million.

  • Protagonist Therapeutics' Non-cash Items rose 154.83% to $152.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $152.9 million, marking a year-over-year increase of 154.83%. This contributed to the annual value of $4.9 million for FY2024, which is 4.04% down from last year.
  • Protagonist Therapeutics' Non-cash Items amounted to $4.9 million in FY2024, which was down 4.04% from $5.1 million recorded in FY2023.
  • Protagonist Therapeutics' Non-cash Items' 5-year high stood at $102.7 million during FY2021, with a 5-year trough of $4.9 million in FY2024.
  • Moreover, its 3-year median value for Non-cash Items was $5.1 million (2023), whereas its average is $5.6 million.
  • Per our database at Business Quant, Protagonist Therapeutics' Non-cash Items spiked by 1,566.67% in 2020 and then plummeted by 93.28% in 2022.
  • Protagonist Therapeutics' Non-cash Items (Yearly) stood at $40.0 million in 2020, then skyrocketed by 156.75% to $102.7 million in 2021, then slumped by 93.28% to $6.9 million in 2022, then declined by 26.34% to $5.1 million in 2023, then dropped by 4.04% to $4.9 million in 2024.